Pharmacologic options available to treat symptomatic intradialytic hypotension

American Journal of Kidney Diseases

Volumn 38, Issue 4 SUPPL. 4, 2001, Pages

  Perazella, Mark A ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cardiomyopathy; Diabetes mellitus; End stage renal disease (ESRD); Hemodialysis (HD); Hypotension; Midodrine; Neuropathy

Indexed keywords

ADRENERGIC RECEPTOR STIMULATING AGENT; ALBUMIN; ALPHA 1 ADRENERGIC RECEPTOR STIMULATING AGENT; CAFFEINE; CARNITINE; DIALYSIS FLUID; EPHEDRINE; FLUDROCORTISONE; FLUOXETINE; MIDODRINE; MINERALOCORTICOID; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; SODIUM; SODIUM CHLORIDE; VASOPRESSIN;

CARDIOMYOPATHY; CLINICAL TRIAL; COMORBIDITY; DIABETES MELLITUS; DRUG EFFICACY; DRUG INDUCED DISEASE; DRUG TOLERABILITY; HEMODIALYSIS; HIGH RISK PATIENT; HUMAN; HYPOTENSION; KIDNEY FAILURE; META ANALYSIS; NEUROPATHY; REVIEW; RISK FACTOR; SYMPTOMATOLOGY;

EID: 0034770527     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/ajkd.2001.28092     Document Type: Article

References (35)

1. Dialysis hypotension: A hemodynamic analysis
2. Preventing and managing hypotension
3. The pathophysiologic basis for hemodialysis-related hypotension
4. Approach to patients with intradialytic hypotension: A focus on therapeutic options
5. "U" curve association of blood pressure and mortality in hemodialysis patients
6. Can hypotension during dialysis be avoided?
7. Prevalence of central autonomic neuropathy in elderly dialysis patients
8. Autonomic dysregulation in patients awaiting kidney transplantation
9. Autonomic insufficiency in uremia as a cause of hemodialysis-induced hypotension
10. Hemodynamic and metabolic effects of hemorrhage in man, with particular reference to the splanchnic circulation
11. Splanchnic erythrocyte content decreases during hemodialysis: A new compensatory mechanism for hypovolemia
12. Local regulation of adrenergic neurotransmission
13. Renal target sites and the mechanism of action of aldosterone
14. Postural hypotension: Causes, clinical features, investigation, and management
15. Effect of caffeine on plasma renin activity, catecholamines and blood pressure
16. Relationship between dialysis induced hypotension and adenosine released by ischemic tissue
17. Vasopressin as vasopressor
18. Hemodynamic effects of lysine-vasopressin in orthostatic hypotension
19. Lysine vasopressin in the treatment of refractory hemodialysis-induced hypotension
20. The pharmacology of carnitine
21. Multicenter trial of L-carnitine in maintenance hemodialysis patients. II. Clinical and biochemical effects
22. Fluoxetine hydrochloride for the treatment of severe refractory orthostatic hypotension
23. Use of sertraline hydrochloride in the treatment of refractory neurocardiogenic syncope in children and adolescents
24. Effect of sertraline hydrochloride on dialysis hypotension
25. Midodrine: A review of its pharmacologic properties and therapeutic use in orthostatic hypotension and secondary hypotensive disorders
26. Midodrine: A new therapy for intradialytic hypotension
27. Efficacy of midodrine vs placebo in neurogenic orthostatic hypotension: A randomized, double-blind multicenter study
28. Neurogenic orthostatic hypotension: A double-blind, placebocontrolled study with midodrine
29. Midodrine efficacy and pharmacokinetics in a patient with recurrent intradialytic hypotension
30. Midodrine treatment for patients with hemodialysis hypotension
31. Midodrine for the treatment of intradialytic hypotension
32. Intradia.lytic hypotension: Is midodrine beneficial in symptomatic hemodialysis patients?
33. Midodrine is effective and safe therapy for intradialytic hypotension over 8 months of follow-up
34. Midodrine and cool dialysate are effective therapies for symptomatic intradialytic hypotension